CO6630186A2 - Polímeros que contienen zwiteriones de alto peso molecular - Google Patents

Polímeros que contienen zwiteriones de alto peso molecular

Info

Publication number
CO6630186A2
CO6630186A2 CO12203725A CO12203725A CO6630186A2 CO 6630186 A2 CO6630186 A2 CO 6630186A2 CO 12203725 A CO12203725 A CO 12203725A CO 12203725 A CO12203725 A CO 12203725A CO 6630186 A2 CO6630186 A2 CO 6630186A2
Authority
CO
Colombia
Prior art keywords
molecular weight
high molecular
zwitterions
polymers containing
containing high
Prior art date
Application number
CO12203725A
Other languages
English (en)
Inventor
Stephen Charles
D Victor Perlroth
Didier G Benoit
Lane A Clizbe
Wayne To
Linda J Zadik
Jeanne M Pratt
Original Assignee
Oligasis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oligasis filed Critical Oligasis
Publication of CO6630186A2 publication Critical patent/CO6630186A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F230/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6881—Cluster-antibody conjugates, i.e. the modifying agent consists of a plurality of antibodies covalently linked to each other or of different antigen-binding fragments covalently linked to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F120/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F120/52—Amides or imides
    • C08F120/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F120/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F130/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F130/02—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/04—Polymerisation in solution
    • C08F2/06—Organic solvent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/46—Polymerisation initiated by wave energy or particle radiation
    • C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/12—Esters of monohydric alcohols or phenols
    • C08F20/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F20/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
    • C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
    • C08F20/10—Esters
    • C08F20/26—Esters containing oxygen in addition to the carboxy oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F30/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
    • C08F30/02—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00—Polymerisation catalysts
    • C08F4/06—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen
    • C08F4/10—Metallic compounds other than hydrides and other than metallo-organic compounds; Boron halide or aluminium halide complexes with organic compounds containing oxygen of alkaline earth metals, zinc, cadmium, mercury, copper or silver
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00—Living radical polymerisation
    • C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2500/00—Characteristics or properties of obtained polyolefins; Use thereof
    • C08F2500/03—Narrow molecular weight distribution, i.e. Mw/Mn < 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerization Catalysts (AREA)
  • Polymerisation Methods In General (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención proporciona polímeros de alto peso molecular de varias ramas que contienen grupos hidrófilos y uno o más agentes funcionales para su aplicación en la industria farmacéutica y métodos para preparar dichos polímeros.
CO12203725A 2010-04-15 2012-11-13 Polímeros que contienen zwiteriones de alto peso molecular CO6630186A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32441310P 2010-04-15 2010-04-15

Publications (1)

Publication Number Publication Date
CO6630186A2 true CO6630186A2 (es) 2013-03-01

Family

ID=44799363

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12203725A CO6630186A2 (es) 2010-04-15 2012-11-13 Polímeros que contienen zwiteriones de alto peso molecular

Country Status (18)

Country Link
US (4) US20140024776A1 (es)
EP (3) EP2558538B1 (es)
JP (5) JP2013534931A (es)
KR (7) KR20230113857A (es)
CN (2) CN103492489A (es)
AU (3) AU2011239434B2 (es)
BR (1) BR112012026118B1 (es)
CA (1) CA2795667C (es)
CL (1) CL2012002881A1 (es)
CO (1) CO6630186A2 (es)
DK (2) DK2558538T3 (es)
ES (2) ES2905690T3 (es)
IL (1) IL222427A0 (es)
LT (2) LT3549963T (es)
MX (1) MX365521B (es)
PT (2) PT2558538T (es)
SI (2) SI3549963T1 (es)
WO (1) WO2011130694A2 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2657628T3 (es) 2006-02-28 2018-03-06 Kodiak Sciences Inc. Conjugados poliméricos que contienen acriloiloxietilfosforilcolina y su preparación
US8765432B2 (en) 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
LT3549963T (lt) * 2010-04-15 2022-03-10 Kodiak Sciences Inc. Didelės molekulinės masės polimerai, kurių sudėtyje yra cviterjonai
US9033159B1 (en) * 2011-06-07 2015-05-19 Clemson University Membrane surface modification
JP5907726B2 (ja) * 2011-12-28 2016-04-26 東邦化学工業株式会社 星型ポリマー及び原子移動ラジカル重合開始剤
US8802235B2 (en) 2012-01-18 2014-08-12 University Of Kansas Drug and imaging agent delivery compositions and methods
JP6234064B2 (ja) * 2012-05-23 2017-11-22 キヤノン株式会社 重合体、前記重合体を用いた核磁気共鳴分析用または磁気共鳴イメージング用の造影剤、化合物、前記重合体を用いた核磁気共鳴分析方法および磁気共鳴イメージング方法
SG11201504235UA (en) * 2012-12-28 2015-07-30 Blend Therapeutics Inc Targeted conjugates encapsulated in particles and formulations thereof
LT3041513T (lt) * 2013-09-08 2020-11-25 Kodiak Sciences Inc. Viii faktoriaus cviterioninių polimerų konjugatai
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
KR20210013299A (ko) 2014-10-17 2021-02-03 코디악 사이언시스 인코포레이티드 부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
WO2016063817A1 (en) * 2014-10-24 2016-04-28 Canon Kabushiki Kaisha Polymer and contrast agent for photoacoustic imaging including the polymer
CN113876962A (zh) * 2015-04-07 2022-01-04 纪念斯隆-凯特琳癌症中心 纳米粒子免疫偶联物
CN104961853A (zh) * 2015-06-03 2015-10-07 青岛农业大学 一种新型苯乙烯微球及其制备方法
EP3397276A4 (en) 2015-12-30 2019-12-18 Kodiak Sciences Inc. ANTIBODIES AND CONJUGATES THEREOF
WO2017147240A1 (en) 2016-02-23 2017-08-31 Tarveda Therapeutics, Inc. Hsp90 targeted conjugates and particles and formulations thereof
CN105837741B (zh) * 2016-05-14 2018-01-02 上海大学 寡聚脯氨酸甲基丙烯酸酯/二甲氨乙基甲基丙烯酸酯共聚物及其制备方法
CN106519147B (zh) * 2016-06-08 2017-10-17 重庆博蓝鹰生物技术有限公司 微纳米材料、其表面用亲水物质共价修饰的产物及制备方法
EP3470443A4 (en) 2016-06-08 2020-02-19 Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China MICRO / NANOMATERIAL, ASSOCIATED PRODUCT WITH COVALENTLY MODIFIED SURFACE USING HYDROPHILIC MATERIAL, AND MANUFACTURING METHOD
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
KR102391351B1 (ko) 2017-08-13 2022-04-28 어플라이드 머티어리얼스, 인코포레이티드 차단 분자들의 가교결합에 의해 선택적 증착을 향상시키는 방법
WO2019143193A1 (ko) 2018-01-19 2019-07-25 주식회사 펩진 재조합 폴리펩타이드 생산용 n-말단 융합 파트너 및 이를 이용하여 재조합 폴리 펩타이드를 생산하는방법
CN109354637A (zh) * 2018-10-13 2019-02-19 菏泽学院 聚n-异丙基丙烯酰胺油凝胶合成方法
CN109880110B (zh) * 2019-02-15 2021-07-27 华东师范大学 含聚（2-乙烯吡啶）聚肽嵌段共聚物及其制备方法和应用
CN109912790A (zh) * 2019-03-04 2019-06-21 西南交通大学 一种具有高抗凝血性的改性聚碳酸酯
US11912784B2 (en) 2019-10-10 2024-02-27 Kodiak Sciences Inc. Methods of treating an eye disorder
WO2021113986A1 (en) * 2019-12-13 2021-06-17 Folium Labs Inc. Complexes comprising a carbohydrate polymer and an active ingredient and processes for their preparation
CN110981810A (zh) * 2019-12-19 2020-04-10 东莞市维琪科技有限公司 一种脱羧肌肽的合成方法
CN111983067B (zh) * 2020-08-05 2023-03-03 河北省药品医疗器械检验研究院(河北省化妆品检验研究中心) 一种注射用拉氧头孢钠聚合物的检测方法及在线鉴定的检测方法
WO2022065263A1 (ja) * 2020-09-25 2022-03-31 日油株式会社 マレイミドポリエチレングリコール脂質の製造方法
JP7417227B2 (ja) 2021-01-28 2024-01-18 国立研究開発法人物質・材料研究機構 空気電池正極用の炭素多孔体の製造方法
CN116270255A (zh) * 2023-02-14 2023-06-23 哈尔滨运美达生物科技有限公司 一种高贴合复合透明质酸钠修复贴及其制备方法
CN117247534B (zh) * 2023-10-20 2024-04-30 浙江恒翔新材料有限公司 一种切削液用改性超支化聚醚的制备方法及其应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162218A (en) 1988-11-18 1992-11-10 The Regents Of The University Of California Conjugated polypeptides and methods for their preparation
GB9301701D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
GB9301702D0 (en) 1993-01-28 1993-03-17 Biocompatibles Ltd New materials
US6156884A (en) 1996-08-05 2000-12-05 Prolinx, Inc. Bifunctional boronic compound complexing reagents and complexes
PT1023442E (pt) 1997-10-16 2011-02-25 Synageva Biopharma Corp Vectores compreendendo um promotor específico do magno para transgénese aviária
JP4162284B2 (ja) * 1998-02-04 2008-10-08 日油株式会社 洗浄剤組成物
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
DE69941223D1 (de) 1998-12-21 2009-09-17 Billig Fritz Chemisch modifizierte enzymen mit mehrfachgeladenen varianten
FR2794459B1 (fr) * 1999-05-19 2004-09-03 Atofina Polyalcoxyamines issues de nitroxydes beta-substitues
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
US6852816B2 (en) 2000-10-06 2005-02-08 Biocompatibles Uk Limited Zwitterionic polymers
US6780428B2 (en) * 2001-06-08 2004-08-24 Labopharm, Inc. Unimolecular polymeric micelles with an ionizable inner core
JP2003064132A (ja) * 2001-08-28 2003-03-05 Nof Corp 重合体、製造方法および乳化・分散剤
US6964859B2 (en) 2001-10-16 2005-11-15 Massachusetts Institute Of Technology Suppressor tRNA system
EP2226316B1 (en) 2002-05-30 2016-01-13 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
SI1545613T1 (sl) 2002-07-31 2011-11-30 Seattle Genetics Inc Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
US7820753B2 (en) * 2003-02-05 2010-10-26 Biocompatibles Uk Limited Block copolymers
CN1208358C (zh) * 2003-07-31 2005-06-29 上海交通大学 含多羟基官能团多臂星状超支化聚合物刷及其制备方法
AU2005216251B2 (en) 2004-02-23 2011-03-10 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
JP4727938B2 (ja) * 2004-02-24 2011-07-20 泰彦 岩崎 リビングラジカル重合開始基を持つポリリン酸の製造方法および用途
JP4727941B2 (ja) * 2004-03-12 2011-07-20 泰彦 岩崎 生分解性重合体の製造方法および用途
CA2786794C (en) 2004-03-23 2017-09-12 Complex Biosystems Gmbh Aromatic polymeric cascade prodrug linker reagent
HUE033776T2 (en) 2004-11-12 2018-01-29 Bayer Healthcare Llc FVIII site-specific modification
DE102006009004A1 (de) * 2006-02-23 2007-09-06 Sustech Gmbh & Co. Kg Multifunktionelle sternförmige Präpolymere, deren Herstellung und Verwendung
ES2657628T3 (es) * 2006-02-28 2018-03-06 Kodiak Sciences Inc. Conjugados poliméricos que contienen acriloiloxietilfosforilcolina y su preparación
JP2007263935A (ja) * 2006-03-30 2007-10-11 Canon Inc 磁性マーカー及びその製造方法
US8445016B2 (en) * 2006-04-14 2013-05-21 Interface Biologics, Inc. Grafted polymers and uses thereof
US7632492B2 (en) 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
CN101511892B (zh) * 2006-06-29 2012-02-29 英维特罗根戴内尔公司 含有多嵌段聚合物的颗粒
WO2008022309A2 (en) 2006-08-18 2008-02-21 F. Hoffmann-La Roche Ag Polyconjugates for in vivo delivery of polynucleotides
JP5111016B2 (ja) * 2006-11-01 2012-12-26 三井化学株式会社 表面親水性ポリオレフィン成形体およびその製造方法
JP5557373B2 (ja) * 2006-11-21 2014-07-23 アボット ラボラトリーズ 薬剤溶出性コーティングにおけるテトラフルオロエチレン、ヘキサフルオロプロピレン、及びフッ化ビニリデンのターポリマーの使用
US8575397B2 (en) * 2007-02-14 2013-11-05 Biocompatibles Uk Limited Derivatisation of biological molecules
CN101053681B (zh) * 2007-04-10 2010-05-19 天津大学 用于血管栓塞材料的温敏性MPC-b-NIPAM二嵌段星型共聚物及制备方法和应用
JP2009042617A (ja) * 2007-08-10 2009-02-26 Canon Inc 静電荷像現像用トナー及びその製造方法
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
CA2718942A1 (en) 2008-03-18 2009-09-24 Seattle Genetics, Inc. Auristatin drug linker conjugates
SI2281006T1 (sl) 2008-04-30 2017-12-29 Immunogen, Inc. Premreževalci in njihova uporaba
JP5575116B2 (ja) * 2008-05-15 2014-08-20 ビオコムパトイブルエス ユーケー リミテド 細胞内抗体送達
JP5344420B2 (ja) * 2008-05-15 2013-11-20 独立行政法人国立循環器病研究センター 遺伝子導入剤及びその製造方法並びに核酸複合体
WO2010126552A1 (en) 2009-04-30 2010-11-04 Immunogen, Inc. Potent cell-binding agent drug conjugates
CN101575402B (zh) * 2009-05-31 2012-06-27 中国科学院化学研究所 一种多臂星型聚合物及其制备方法
DK2260873T3 (da) * 2009-06-08 2019-09-16 Biocompatibles Uk Ltd Pcylering af proteiner
KR101159674B1 (ko) * 2009-11-16 2012-06-25 주식회사 케이씨씨 모노실란의 정제방법
US8765432B2 (en) * 2009-12-18 2014-07-01 Oligasis, Llc Targeted drug phosphorylcholine polymer conjugates
LT3549963T (lt) * 2010-04-15 2022-03-10 Kodiak Sciences Inc. Didelės molekulinės masės polimerai, kurių sudėtyje yra cviterjonai

Also Published As

Publication number Publication date
WO2011130694A3 (en) 2014-03-20
CN106432557A (zh) 2017-02-22
EP2558538A2 (en) 2013-02-20
KR20130097636A (ko) 2013-09-03
SI2558538T1 (sl) 2019-10-30
EP3549963A2 (en) 2019-10-09
AU2017201930A1 (en) 2017-04-13
JP2022165998A (ja) 2022-11-01
LT3549963T (lt) 2022-03-10
WO2011130694A2 (en) 2011-10-20
EP3549963A3 (en) 2019-12-25
ES2905690T3 (es) 2022-04-11
KR20210084676A (ko) 2021-07-07
IL222427A0 (en) 2012-12-31
SI3549963T1 (sl) 2022-04-29
CA2795667A1 (en) 2011-10-20
EP2558538B1 (en) 2019-07-03
JP6568748B2 (ja) 2019-08-28
AU2011239434A1 (en) 2012-11-08
CL2012002881A1 (es) 2013-07-05
KR20230113857A (ko) 2023-08-01
JP2013534931A (ja) 2013-09-09
AU2017201930B2 (en) 2019-04-18
EP2558538A4 (en) 2016-08-17
KR20170137938A (ko) 2017-12-13
JP2018087330A (ja) 2018-06-07
CA2795667C (en) 2018-09-04
CN103492489A (zh) 2014-01-01
PT2558538T (pt) 2019-10-10
KR20200067958A (ko) 2020-06-12
DK3549963T3 (da) 2022-02-14
JP7217245B2 (ja) 2023-02-02
DK2558538T3 (da) 2019-08-05
MX365521B (es) 2019-06-06
US20210402015A1 (en) 2021-12-30
US20140024776A1 (en) 2014-01-23
EP3549963B1 (en) 2022-01-12
AU2011239434B2 (en) 2015-04-30
BR112012026118B1 (pt) 2021-01-05
AU2015207898A1 (en) 2015-08-20
KR20220039860A (ko) 2022-03-29
LT2558538T (lt) 2019-09-25
ES2742216T3 (es) 2020-02-13
JP2016040371A (ja) 2016-03-24
KR20180130008A (ko) 2018-12-05
KR102562175B1 (ko) 2023-07-31
KR102416359B1 (ko) 2022-07-01
PT3549963T (pt) 2022-02-02
US20170143841A1 (en) 2017-05-25
EP4029510A1 (en) 2022-07-20
MX2012011876A (es) 2012-11-30
JP6754749B2 (ja) 2020-09-16
JP2020189967A (ja) 2020-11-26
US20200171179A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
CO6630186A2 (es) Polímeros que contienen zwiteriones de alto peso molecular
CO6650338A2 (es) Antígenos de tuberculosis modificados
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
CL2016001166A1 (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia
CO6551686A2 (es) Inmunoglobinas con dominio variable dual y usos de las mismas
BR112014016062B8 (pt) método para fabricação de um artigo limpável, artigo limpável e método para utilizar um artigo limpável
CR20140441A (es) Anticuerpos anti-lgr5 e inmunoconjugados
BR112014019333A8 (pt) Artigo, método, e, composição de revestimento por pó
CO6791606A2 (es) Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
CL2014002954A1 (es) Composicion farmaceutica que contiene anticuerpos anti-il-23p19 y sus usos.
BR112014010631A2 (pt) inibidores de pak para o tratamento da síndrome do x frágil
BR112013020500A2 (pt) anticorpo isolado, recombinante ou purificado
BR112013004490A2 (pt) aparelho para medir propriedade termodinâmicas de fluidos de reservatório, e método para medir propriedades termodinâmicas de fluidos de reservatório
BRPI1006170A2 (pt) película de polietileno de peso molecular ultra alto, processo para fabricar película de polietileno de peso molecular ultra alto, uso de uma película de polietileno de peso molecular ultra, e, elementos
BR112012002774A2 (pt) dispositivo prendedor para um transportador estrela ou uma unidade de condução similar e transportador estrela para recipientes ou corpos similares
UA110470C2 (ru) Антидот антикоагулянта
AR088920A1 (es) Purificacion de anticuerpos anti-c-met
BR112015009718A2 (pt) composição de matéria e artigo.
BR112012021229A2 (pt) reciclagem de partículas de polímero superabsorvente.
CL2014002066A1 (es) Procedimiento para la preparación de películas de grafeno ó materiales grafénicos sobre sustratos no metálicos.
BR112014030334A2 (pt) aparelho de interface entre um sistema de automação de laboratório e uma plataforma para a manipulação de líquidos e consumíveis no campo da biologia molecular.
BR112016008477A2 (pt) Corpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica e usos do anticorpo
BR112013011190A2 (pt) tabuleta de desativação de ponto de venda e método
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
BR112013000779A2 (pt) composições farmacêuticas de combinação, métodos de tratamento de paciente e uso de forma potencializada ativada de anticorpo para receptor at1 de angiotensina ii e forma potencializada ativada de anticorpo para sintase no endotelial

Legal Events

Date Code Title Description
FC Application refused